Close

Epizyme (EPZM) Annoucnes $120M Common Stock Offering

January 5, 2016 4:02 PM EST Send to a Friend
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapeutics for cancer patients, today announced that it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login